Ullink Extends OMS with Broker Solution for SI Regime

Modular extension for SI compliance to Ullink OMS aims to simply quoting process for brokers under new regulations.

paris
Paris-based Ullink has launched three additions to its OMS platform this year, including UL Quote, ahead of January's Mifid II deadline.

The UL Quote solution has been designed in collaboration with an undisclosed European bank, which will also act as the first Ullink client to implement, and aims to simplify the management of client RFQ (request-for-quote) workflows for brokers in accordance with the new rules around systematic internalizers (SIs) under the revised Markets in Financial Instruments Directive, or Mifid II.

The solution’s modular design was built to further extend the vendor’s order management system (OMS) and

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@waterstechnology.com or view our subscription options here: http://subscriptions.waterstechnology.com/subscribe

You are currently unable to copy this content. Please contact info@waterstechnology.com to find out more.

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to Waterstechnology? View our subscription options

Register for free

Access two articles, our IMD and Waters Wraps, plus a member newsletter. Find out more.

All fields are mandatory unless otherwise highlighted.

This address will be used to create your account

DORA stalls over identifier dispute

A disagreement over how to classify third-party tech providers on a reporting form known as the “register of information” has held up preparations for the highly anticipated operational resiliency rule in Europe.

Most read articles loading...

You need to sign in to use this feature. If you don’t have a WatersTechnology account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here